    <SEC-DOCUMENT>0001161697-23-000409-index.html : 20230717
    <SEC-HEADER>0001161697-23-000409.hdr.sgml : 20230717
    <ACCEPTANCE-DATETIME>20230717163007
    ACCESSION NUMBER:		0001161697-23-000409
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20221231
    FILED AS OF DATE:		20230717
    DATE AS OF CHANGE:		20230717
    EFFECTIVENESS DATE:		20230717

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			CATALYST PHARMACEUTICALS, INC.
    		CENTRAL INDEX KEY:			0001369568
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		IRS NUMBER:				000000000
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-33057
    		FILM NUMBER:		231091950

    	BUSINESS ADDRESS:
    		STREET 1:		355 ALHAMBRA CIRCLE
    		STREET 2:		SUITE 801
    		CITY:			CORAL GABLES
    		STATE:			FL
    		ZIP:			33134
    		BUSINESS PHONE:		(305) 529-2522

    	MAIL ADDRESS:
    		STREET 1:		355 ALHAMBRA CIRCLE
    		STREET 2:		SUITE 801
    		CITY:			CORAL GABLES
    		STATE:			FL
    		ZIP:			33134

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	CATALYST PHARMACEUTICAL PARTNERS, INC.
    		DATE OF NAME CHANGE:	20110215

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Catalyst Pharmaceutical Partners, Inc.
    		DATE OF NAME CHANGE:	20060719
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>form_ars-2022.pdf
    <DESCRIPTION>FORM ARS ANNUAL REPORT TO SHAREHOLDERS FOR 12-31-2022
    <TEXT>
    Document 1 - file: form_ars-2022.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>